Related Experiment Video
Updated: Aug 13, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[Pelotherapy in ischemic heart disease]
Abstract:
Immediate and long-term responses to pelotherapy were evaluated in 80 patients with ischemic heart disease (IHD) combined with osteochondrosis. The effect was registered in 75-82% of the IHD patients with painless disease or angina pectoris functional class II and III. The clinical improvement was confirmed by 24-hour ECG monitoring findings and bicycle ergometry results. The effect persisted for 12 months in the majority of patients with IHD functional class II and with painless IHD, but only in 15% of those with IHD functional class III. Contraindications to peloids are specified.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pericarditis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

